by InSitu Biologics | Aug 15, 2020 | General
InSitu Biologics has made considerable progress executing our business plan over the past several months, even in the midst of ongoing COVID-19 challenges. We recently raised over $2 million in a convertible note financing round, received a pre-investigational new...
by InSitu Biologics | Apr 10, 2020 | General
InSitu Biologics has continued to make great strides over the past few months. We have successfully submitted our Pre-IND application to the FDA, as well as applied for a National Institute of Health federal grant to support our development costs. During this time of...
